Member Info for Truthfactory

Indeed-it’s now 66p.

Cash call coming Laura-fill your boots.Just my opinion

I hold Gen and took part in the placing-too cheap but this was led by aggressive holders dictating the price

Some of us knew the CEO at Avid-and that’s precisely why I agree with what you are saying!

Net cash was £0.92m at 31/12.It was £1.1m 30/6.

Looks like the refinanced some machinery to put more cash in the BS.

Looking forward, I expect cash balances to fall with lower royalty income,which has highest margin.

Is a cash call coming?I expect an attempt to raise a couple of million before the summer as headroom tight.Just my view

I’m looking forward Laura, not back.This company is seeing a reduction in its previous impressive margin and the headroom on cash is tight.

Try spending distributable reserves in the checkout at Tescos and let us now how you get on-I’m sticking with good old hard cash.

You clearly weren’t a shareholder in Avid then.

Cash call coming in my view-way too tight.I reckon within the next couple of months

So is the SP-a lot of hope and expectation in this one with limited cash and therefore very little ‘currency’ to buy anything

Admin expenses of around £4m pa in my opinion-was £3.6m in 2024.I think cash will be tight on these forecasts so I think a fundraise will be needed in next few months.Not a good time to raise so be careful

It will run out of cash like Maughan’s last business-give me cashflow rather than pipelines

Looks like a well run business now

Market cap is very low for a company with their products and aspiration .Im very positive

And EIS

100pc Bagpuss-not a market to ask for money with your arm up your back

I participated in the Placing and was happy to go along with 1.5p m, the original number.But in this market, the bigger shareholders dictate the terms and it was done at 1p.

This is incredibly cheap

Painful pricing but necessary to keep the wagons rolling at pace.

Agreed!

I think the company has simply outgrown Zeus-I know Richard Hughes but Zeus is an excellent company with many skilled operators.They raised the cash last year which was no small achievement but if you have global aspirations in pharma, you need US advisors at some stage.

The CEO is very smart as I’ve said before-this move to a new Advisor is all part of the journey

Fevertree-chill out .This is positive stuff.This time next year Rodney..

Zeus are positive in their morning research note.

A bit harsh-this is going to be the mother of all turnarounds and we’re on our way.